Evidence map›Paper›PMID 31568879›Full record

ArticleActa biomaterialia2019

Inflammation via myeloid differentiation primary response gene 88 signaling mediates the fibrotic response to implantable synthetic poly(ethylene glycol) hydrogels.

Luke D Amer, Leila S Saleh, Cierra Walker, Stacey Thomas, William J Janssen, Scott Alper, Stephanie J Bryant

Open access · greenAbstract read
In one paragraph

Article in Acta biomaterialia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Polyethylene Glycols Stimulate CaInternational journal of nanomedicine · 2024
    Article
  8. Article
  9. Consequences of poly(ethylene oxide) and poloxamer P188 on transcription in healthy and stressed myoblasts.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Luke D AmerDepartment of Chemical and Biological Engineering, University of Colorado, Boulder, CO 80309, United States; BioFrontiers Institute, University of Colorado, Boulder, CO 80309, United States.
Leila S SalehDepartment of Chemical and Biological Engineering, University of Colorado, Boulder, CO 80309, United States.
Cierra WalkerBioFrontiers Institute, University of Colorado, Boulder, CO 80309, United States; Material Science and Engineering Program, University of Colorado, Boulder, CO 80309, United States.
Stacey ThomasDivision of Pulmonary, Sleep and Critical Care Medicine, National Jewish Health, Denver, CO 80206, United States.
William J JanssenDivision of Pulmonary, Sleep and Critical Care Medicine, National Jewish Health, Denver, CO 80206, United States; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver, Aurora, CO 80045, United States.
Scott AlperDepartment of Biomedical Research and Center for Genes, Environment and Health, National Jewish Health, Denver, CO 80206, United States; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO 80045, United States.
Stephanie J BryantDepartment of Chemical and Biological Engineering, University of Colorado, Boulder, CO 80309, United States; BioFrontiers Institute, University of Colorado, Boulder, CO 80309, United States; Material Science and Engineering Program, University of Colorado, Boulder, CO 80309, United States. Electronic address: stephanie.bryant@colorado.edu.
University of Colorado Boulder · USNational Jewish Health · US

Funding

Regulation of innate immunity by a novel protein interaction networkR21AI132827 · NIAID · NATIONAL JEWISH HEALTH · PI ALPER, SCOTT · 2019 to 2020
$450k
The Interplay between Macrophages and Differentiating MSCs in Cell-Laden HydrogelR21AR064436 · NIAMS · UNIVERSITY OF COLORADO · PI BRYANT, STEPHANIE J · 2013 to 2014
$358k
Single-molecule resolution of DAMPs and their impact on the FBRR21AR071550 · NIAMS · UNIVERSITY OF COLORADO · PI BRYANT, STEPHANIE J, KAAR, JOEL · 2018 to 2019
$348k
NIAID NIH HHS R21 AI132827NIAMS NIH HHS R21 AR064436NIAMS NIH HHS R21 AR071550
6 · The paper itself

Abstract

Synthetic hydrogels, such as poly(ethylene glycol) (PEG), are promising for a range of in vivo applications. However, like all non-biological biomaterials, synthetic hydrogels including PEG elicit a foreign body response (FBR). The FBR is thought to be initiated by adsorbed protein that is recognized by and subsequently activates inflammatory cells, notably macrophages, and culminates with fibrotic encapsulation. However, the molecular mechanisms that drive the FBR are not well understood. Toll-like receptors (TLRs) are key receptors that recognize pathogens, but also recognize altered host proteins that display damage-associated molecular patterns (DAMPs). Thus TLRs may play a role in the FBR. Here, we investigated myeloid differentiation primary response gene 88 (MyD88), a signaling adaptor protein that mediates inflammatory cytokine production induced by most TLRs. An in vitro model was used consisting of macrophages cultured on the surface of synthetic hydrogels, specifically PEG, with pre-adsorbed serum proteins. Our in vitro findings demonstrate that MyD88-dependent signaling is the predominant inflammatory pathway in macrophage activation to synthetic hydrogels. When stimulated with TLR agonists to mimic additional DAMPs present in vivo, MyD88-dependent signaling was also the predominant pathway in macrophage activation. An in vivo model of PEG hydrogels implanted subcutaneously in wild-type and MyD88

Indexed as

Signal TransductionAlarminsAnimalsFibrosisForeign-Body ReactionHydrogelsImplants, ExperimentalInflammationMacrophage ActivationMaleMice, Inbred C57BLMyeloid Differentiation Factor 88Polyethylene GlycolsAlarminsHydrogelsMyeloid Differentiation Factor 88Polyethylene GlycolsFibrous encapsulationForeign body responseMacrophageMyD88PEG hydrogel

Identifiers

PMID31568879
PMCPMC6980661
OpenAlexW2976534380

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.